161 related articles for article (PubMed ID: 33614822)
1. Vinblastine treatment decreases the undifferentiated cell contamination of human iPSC-derived intestinal epithelial-like cells.
Ichikawa M; Negoro R; Kawai K; Yamashita T; Takayama K; Mizuguchi H
Mol Ther Methods Clin Dev; 2021 Mar; 20():463-472. PubMed ID: 33614822
[TBL] [Abstract][Full Text] [Related]
2. Generation of intestinal organoids derived from human pluripotent stem cells for drug testing.
Yoshida S; Miwa H; Kawachi T; Kume S; Takahashi K
Sci Rep; 2020 Apr; 10(1):5989. PubMed ID: 32249832
[TBL] [Abstract][Full Text] [Related]
3. Plasma-activated medium selectively eliminates undifferentiated human induced pluripotent stem cells.
Matsumoto R; Shimizu K; Nagashima T; Tanaka H; Mizuno M; Kikkawa F; Hori M; Honda H
Regen Ther; 2016 Dec; 5():55-63. PubMed ID: 31245502
[TBL] [Abstract][Full Text] [Related]
4. Tumorigenicity-associated characteristics of human iPS cell lines.
Yasuda S; Kusakawa S; Kuroda T; Miura T; Tano K; Takada N; Matsuyama S; Matsuyama A; Nasu M; Umezawa A; Hayakawa T; Tsutsumi H; Sato Y
PLoS One; 2018; 13(10):e0205022. PubMed ID: 30286143
[TBL] [Abstract][Full Text] [Related]
5. Human induced pluripotent stem cell-derived lung progenitor and alveolar epithelial cells attenuate hyperoxia-induced lung injury.
Shafa M; Ionescu LI; Vadivel A; Collins JJP; Xu L; Zhong S; Kang M; de Caen G; Daneshmand M; Shi J; Fu KZ; Qi A; Wang Y; Ellis J; Stanford WL; Thébaud B
Cytotherapy; 2018 Jan; 20(1):108-125. PubMed ID: 29056548
[TBL] [Abstract][Full Text] [Related]
6. A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells.
Hirai T; Kono K; Sawada R; Kuroda T; Yasuda S; Matsuyama S; Matsuyama A; Koizumi N; Utoguchi N; Mizuguchi H; Sato Y
Sci Rep; 2021 Jun; 11(1):11407. PubMed ID: 34075124
[TBL] [Abstract][Full Text] [Related]
7. Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells.
Kuroda T; Yasuda S; Kusakawa S; Hirata N; Kanda Y; Suzuki K; Takahashi M; Nishikawa S; Kawamata S; Sato Y
PLoS One; 2012; 7(5):e37342. PubMed ID: 22615985
[TBL] [Abstract][Full Text] [Related]
8. Tumorigenic risk of human induced pluripotent stem cell explants cultured on mouse SNL76/7 feeder cells.
Kamada M; Mitsui Y; Kumazaki T; Kawahara Y; Matsuo T; Takahashi T
Biochem Biophys Res Commun; 2014 Oct; 453(3):668-73. PubMed ID: 25305485
[TBL] [Abstract][Full Text] [Related]
9. Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas.
Kamada M; Mitsui Y; Matsuo T; Takahashi T
Hum Cell; 2016 Jan; 29(1):1-9. PubMed ID: 26069211
[TBL] [Abstract][Full Text] [Related]
10. Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application.
Ito E; Miyagawa S; Takeda M; Kawamura A; Harada A; Iseoka H; Yajima S; Sougawa N; Mochizuki-Oda N; Yasuda S; Sato Y; Sawa Y
Sci Rep; 2019 Feb; 9(1):1881. PubMed ID: 30760836
[TBL] [Abstract][Full Text] [Related]
11. Relationship Between the Efficacy of Cardiac Cell Therapy and the Inhibition of Differentiation of Human iPSC-Derived Nonmyocyte Cardiac Cells Into Myofibroblast-Like Cells.
Gao L; Yang L; Wang L; Geng Z; Wei Y; Gourley G; Zhang J
Circ Res; 2018 Dec; 123(12):1313-1325. PubMed ID: 30566050
[TBL] [Abstract][Full Text] [Related]
12. In vitro detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human induced pluripotent stem cells.
Kuroda T; Yasuda S; Sato Y
Methods Mol Biol; 2014; 1210():183-92. PubMed ID: 25173169
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury.
Okubo T; Iwanami A; Kohyama J; Itakura G; Kawabata S; Nishiyama Y; Sugai K; Ozaki M; Iida T; Matsubayashi K; Matsumoto M; Nakamura M; Okano H
Stem Cell Reports; 2016 Oct; 7(4):649-663. PubMed ID: 27666789
[TBL] [Abstract][Full Text] [Related]
14. Liver specification of human iPSC-derived endothelial cells transplanted into mouse liver.
Yap KK; Schröder J; Gerrand YW; Dobric A; Kong AM; Fox AM; Knowles B; Banting SW; Elefanty AG; Stanley EG; Yeoh GC; Lockwood GP; Cogger VC; Morrison WA; Polo JM; Mitchell GM
JHEP Rep; 2024 May; 6(5):101023. PubMed ID: 38681862
[TBL] [Abstract][Full Text] [Related]
15. [In vitro tumorigenicity tests for process control of health care products derived from human induced pluripotent stem cells].
Sato Y
Yakugaku Zasshi; 2013; 133(12):1381-8. PubMed ID: 24292187
[TBL] [Abstract][Full Text] [Related]
16. In vitro methods to ensure absence of residual undifferentiated human induced pluripotent stem cells intermingled in induced nephron progenitor cells.
Tsujimoto H; Katagiri N; Ijiri Y; Sasaki B; Kobayashi Y; Mima A; Ryosaka M; Furuyama K; Kawaguchi Y; Osafune K
PLoS One; 2022; 17(11):e0275600. PubMed ID: 36378656
[TBL] [Abstract][Full Text] [Related]
17. Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine.
Akazawa T; Yoshida S; Ohnishi S; Kanazu T; Kawai M; Takahashi K
Drug Metab Dispos; 2018 Nov; 46(11):1497-1506. PubMed ID: 30135242
[TBL] [Abstract][Full Text] [Related]
18. Efficient Differentiation of Human Induced Pluripotent Stem Cell (hiPSC) Derived Hepatocyte-Like Cells on hMSCs Feeder.
Mobarra N; Soleimani M; Kouhkan F; Hesari Z; Lahmy R; Mossahebi-Mohammadi M; Arefian E; Jaafarpour Z; Nasiri H; Pakzad R; Tavakoli R; Pasalar P
Int J Hematol Oncol Stem Cell Res; 2014 Oct; 8(4):20-9. PubMed ID: 25774264
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of an undifferentiated state of human induced pluripotent stem cells through migration-dependent regulation of the balance between cell-cell and cell-substrate interactions.
Kim MH; Kino-oka M
J Biosci Bioeng; 2015 Jun; 119(6):617-22. PubMed ID: 25468424
[TBL] [Abstract][Full Text] [Related]
20. Toward the realization of cardiac regenerative medicine using pluripotent stem cells.
Kishino Y; Fujita J; Tohyama S; Okada M; Tanosaki S; Someya S; Fukuda K
Inflamm Regen; 2020; 40():1. PubMed ID: 31938077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
